419 related articles for article (PubMed ID: 24134145)
41. Bullous erythema nodosum leprosum manifesting in the post partum period with unusual features.
Verma R; Vasudevan B; Pragasam V; Moorchung N; Mitra D; Gopal M
Lepr Rev; 2015 Mar; 86(1):96-101. PubMed ID: 26065152
[TBL] [Abstract][Full Text] [Related]
42. Lepromatous leprosy presenting with type II reaction before and type I reaction after treatment.
Robati RM; Mozafari N; Bidari-Zerehpoosh F; Niknejad N; Bizaval Z
Dermatol Online J; 2020 Sep; 26(9):. PubMed ID: 33054941
[TBL] [Abstract][Full Text] [Related]
43. Reaction cases treated at the Regional Leprosy Training and Research Institute, Aska, Orissa: a retrospective analysis.
Santaram V; Porichha D
Indian J Lepr; 2004; 76(4):310-20. PubMed ID: 16119141
[TBL] [Abstract][Full Text] [Related]
44. Concomitant lucio phenomenon and erythema nodosum in a leprosy patient: clues for their distinct pathogeneses.
Benard G; Sakai-Valente NY; Bianconcini Trindade MA
Am J Dermatopathol; 2009 May; 31(3):288-92. PubMed ID: 19384072
[TBL] [Abstract][Full Text] [Related]
45. Erythema nodosum leprosum mimicking Sweet's syndrome: an uncommon presentation.
Mahajan VK; Abhinav C; Mehta KS; Chauhan PS
Lepr Rev; 2014 Dec; 85(4):322-7. PubMed ID: 25675656
[TBL] [Abstract][Full Text] [Related]
46. Role of azathioprine in preventing recurrences in a patient of recurrent erythema nodosum leprosum.
Verma KK; Srivastava P; Minz A; Verma K
Lepr Rev; 2006 Sep; 77(3):225-9. PubMed ID: 17172003
[TBL] [Abstract][Full Text] [Related]
47. A rare variant of erythema nodosum leprosum: a case report.
Dave S; Thappa DM; Nori AV; Jayanthi S
Dermatol Online J; 2003 Dec; 9(5):11. PubMed ID: 14996384
[TBL] [Abstract][Full Text] [Related]
48. Erythema nodosum leprosum in subgroups of lepromatous leprosy.
Bhargava P; Kuldeep CM; Mathur NK
Lepr Rev; 1997 Dec; 68(4):373-5. PubMed ID: 9503874
[No Abstract] [Full Text] [Related]
49. Erythema nodosum leprosum and reversal reaction in 2 cases of imported leprosy.
Pulido-Pérez A; Mendoza-Cembranos MD; Avilés-Izquierdo JA; Suárez-Fernández R
Actas Dermosifiliogr; 2013 Dec; 104(10):915-9. PubMed ID: 23177396
[TBL] [Abstract][Full Text] [Related]
50. Whole blood transcriptomics reveals the enrichment of neutrophil activation pathways during erythema nodosum leprosum reaction.
Rosa TLSA; Leal-Calvo T; Tavares IF; Mendes MA; Dias AA; Piauy MHDS; Barboza MFDS; Kapuscinski M; Costa FDMR; Marques MAM; Belone AFF; Sales AM; Hacker MA; Moreira MBP; Belisle JT; Moraes MO; Pessolani MCV; Schmitz V
Front Immunol; 2024; 15():1366125. PubMed ID: 38715615
[TBL] [Abstract][Full Text] [Related]
51. A case of recurrent steroid-dependent severe type 2 lepra reaction treated successfully with colchicine.
Sachdeva S; Sinha S; Sardana K
Int J Mycobacteriol; 2021; 10(4):472-474. PubMed ID: 34916470
[TBL] [Abstract][Full Text] [Related]
52. [Persistent type 2 lepra reaction (erythema nodosum) and clofazimine-induced lethal enteropathy].
Rodríguez G; Pinto R; López F; Gómez Y
Biomedica; 2009 Mar; 29(1):18-24. PubMed ID: 19753835
[TBL] [Abstract][Full Text] [Related]
53. Erythema nodosum leprosum: reactional leprosy.
Cuevas J; Rodríguez-Peralto JL; Carrillo R; Contreras F
Semin Cutan Med Surg; 2007 Jun; 26(2):126-30. PubMed ID: 17544965
[TBL] [Abstract][Full Text] [Related]
54. Studies of human leprosy lesions in situ using suction-induced blisters: cell changes with IgM antibody to PGL-1 and interleukin-2 receptor in clinical subgroups of erythema nodosum leprosum.
Bhoopat L; Scollard DM; Theetranont C; Chiewchanvit S; Nelson DL; Utaipat U
Asian Pac J Allergy Immunol; 1991 Dec; 9(2):107-19. PubMed ID: 1807258
[TBL] [Abstract][Full Text] [Related]
55. Atypical Hansen's disease presenting as florid verrucous plaques on the lower extremities: a case report.
Yuchua-Guillen A; Dofitas BL
Int J Dermatol; 2012 Jun; 51(6):697-701. PubMed ID: 22607288
[TBL] [Abstract][Full Text] [Related]
56. Lessons of leprosy: the emergence of TH17 cytokines during type II reactions (ENL) is teaching us about T-cell plasticity.
Martiniuk F; Giovinazzo J; Tan AU; Shahidullah R; Haslett P; Kaplan G; Levis WR
J Drugs Dermatol; 2012 May; 11(5):626-30. PubMed ID: 22527432
[TBL] [Abstract][Full Text] [Related]
57. Deep vein thrombosis in a patient with lepromatous leprosy receiving thalidomide to treat leprosy reaction.
Hebe Petiti-Martin G; Villar-Buill M; de la Hera I; Fuertes L; Burgués-Calderón M; Rivera-Díaz R; Vanaclocha F
Actas Dermosifiliogr; 2013 Jan; 104(1):67-70. PubMed ID: 22705284
[TBL] [Abstract][Full Text] [Related]
58. Vasculonecrotic reactions in leprosy.
Fogagnolo L; de Souza EM; Cintra ML; Velho PE
Braz J Infect Dis; 2007 Jun; 11(3):378-82. PubMed ID: 17684644
[TBL] [Abstract][Full Text] [Related]
59. Annular vesiculobullous eruptions in type 2 reaction in borderline lepromatous leprosy: a case report.
Kar HK; Raina A; Sharma PK; Bhardwaj M
Indian J Lepr; 2009; 81(4):205-8. PubMed ID: 20704077
[TBL] [Abstract][Full Text] [Related]
60. Leprosy reactions in postelimination stage: the Bangladesh experience.
Mowla MR; Ara S; Mizanur Rahman AFM; Tripura SP; Paul S
J Eur Acad Dermatol Venereol; 2017 Apr; 31(4):705-711. PubMed ID: 27859670
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
